GGrantIndex
Sort

11,323 grants matching glioblastoma

Molecular MRI of Radiation Necrosis in Preclinical Models

$214,715
Jinyuan Zhou · Johns Hopkins University · R21 · FY2012 · EB

ENHANCING GLIOMA IMMUNOTHERAPY WITH TEMODAR-INDUCED LYMPHOPENIA AND A MULTIVALENT

$214,513
John H Sampson · Duke University · P50 · FY2012 · NS

Preclinical Validation of Polyvalent siRNA Gold Nanoparticle Conjugates as anti-G

$214,267
Alexander H. Stegh · Northwestern University At Chicago · U54 · FY2010 · CA

Posttranslational regulation of augurin, a new secretory tumor suppressor

$214,088
Akihiko Ozawa · Torrey Pines Inst For Molecular Studies · R21 · FY2014 · NS

Incorporation of Novel MADR-GESTALT Technology into UCLA SPORE in Brain Cancer

$214,029
Linda M Liau · University Of California Los Angeles · P50 · FY2021 · CA

Novel mouse models using MADR-GESTALT technology to accelerate glioma research

$214,029
Linda M Liau · University Of California Los Angeles · P50 · FY2021 · CA

Project 4-Oncomodulatory role of HCMV in glial tumors

$213,954
Donna M Neumann · Lsu Health Sciences Center · P20 · FY2018 · GM

REGULATION OF GBM INVASIVE GROWTH BY PROTEIN KINASE C-ETA

$213,924
Isa M Hussaini · University Of Virginia · R01 · FY2008 · CA

PROTEOLYTIC CONTROL OF GLIOBLASTOMA

$213,854
Swapan K Ray · Medical University Of South Carolina · R01 · FY2006 · CA

Regulation of RTKs by the SETA/CIN85 Complex in Glioma

$213,815
Oliver Bogler · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA

Regulation of RTKs by the SETA/CIN85 Complex in Glioma

$213,815
Oliver Bogler · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA

Biorepository core and bioststistics

$213,808
Bob S Carter · Massachusetts General Hospital · P01 · FY2012 · CA

Toxicology in the 21st Century Program (Tox21) - Genomic Toxicology

$213,767
David Gerhold · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR

High-Resolution CGH Characterization of Brain Tumors

$213,675
Duke University · R21 · FY2004 · NS

Analysis of Migration Associated Treatment Resistance in Glioblastoma to Identify Novel Therapeutics

$213,668
James Battiste · University Of Oklahoma Hlth Sciences Ctr · P20 · FY2020 · GM

IDENTIFICATION OF MOLECULAR BIOMARKERS FOR INVASIVE GLIOBLASTOMA CELL STATES AND TUMOR MICROENVIRONMENT MODULATION

$213,501
University Health Network · · FY2025 · Defense Health Agency

A deep-transfer-learning framework to transfer clinical information to single cells and spatial locations in cancer tissues

$213,483
Travis Steele Johnson · Indiana University Indianapolis · R21 · FY2022 · CA

Selective Differentiation of Glioblastoma Stem Cells

$213,471
Samuel D Rabkin · Massachusetts General Hospital · R21 · FY2013 · CA

Prevention of radiation-induced neurocognitive dysfunction by induced adult neural stem cell

$213,422
Mihoko Kai · Johns Hopkins University · R21 · FY2017 · CA

The role of ECM-mediated mechanosignaling on regional immunosuppression in GBM

$213,030
Joseph Chen · University Of Louisville · P20 · FY2024 · GM

The Proneural Perivascular Niche and Therapeutic Response

$213,026
Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2015 · CA

Core 2: Neuro-Imaging Core (NIC)

$212,987
Benjamin M. Ellingson · University Of California Los Angeles · P50 · FY2025 · CA

Intedrated Imagaing and Tissue Biomarkers in Glioblastoma Multiforme Post Therapy

$212,875
Susan M Chang · University Of California, San Francisco · P01 · FY2008 · CA

GEMZAR--MECHANISMS OF CYTOTOXICITY &RADIOSENSITIZATION

$212,851
University Of Michigan At Ann Arbor · R01 · FY2002 · CA

Biostatistics and Bioinformatics Core

$212,704
James E Herndon · Duke University · P50 · FY2023 · CA